Aeterna Zentaris Inc (NASDAQ:AEZS)
| 0.3372 Delayed Data As of 3:54pm ET |  -0.0018 / -0.53%Today’s Change | 0.33 Today|||52-Week Range 3.62 | -5.09% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $43.3M |
Company Description
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.
Contact Information
Æterna Zentaris, Inc. 315 Sigma Drive Charleston South Carolina 29486 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Klaus Wolfgang Paulini | President, Chief Executive Officer & Director |
| Leslie Auld | Chief Financial Officer & Senior Vice President |
| Michael Teifel | Chief Scientific Officer |
| Nicola Ammer | Chief Medical Officer & VP-Clinical Development |
| Matthias Gerlach | Vice President-Manufacturing & Supply Chain |
